These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 26704150)
21. The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease--a prospective study. Happe S; Berger K; J Neurol; 2001 Dec; 248(12):1062-7. PubMed ID: 12013583 [TBL] [Abstract][Full Text] [Related]
23. Dissociated resting-state functional networks between the dream recall frequency and REM sleep percentage. Zou Q; Zhou S; Xu J; Su Z; Li Y; Ma Y; Sun H; Wu CW; Gao JH Neuroimage; 2018 Jul; 174():248-256. PubMed ID: 29544817 [TBL] [Abstract][Full Text] [Related]
24. Hippocampal subfield atrophy in patients with Parkinson's disease and psychosis. Lenka A; Ingalhalikar M; Shah A; Saini J; Arumugham SS; Hegde S; George L; Reddy V; Reddy YCJ; Yadav R; Pal PK J Neural Transm (Vienna); 2018 Sep; 125(9):1361-1372. PubMed ID: 29858658 [TBL] [Abstract][Full Text] [Related]
26. Dream recall after sleep interruption in brain-injured patients. Murri L; Massetani R; Siciliano G; Giovanditti L; Arena R Sleep; 1985 Dec; 8(4):356-62. PubMed ID: 3880176 [TBL] [Abstract][Full Text] [Related]
27. Beyond the neuropsychology of dreaming: Insights into the neural basis of dreaming with new techniques of sleep recording and analysis. Cipolli C; Ferrara M; De Gennaro L; Plazzi G Sleep Med Rev; 2017 Oct; 35():8-20. PubMed ID: 27569701 [TBL] [Abstract][Full Text] [Related]
28. Dream Recall Frequencies and Dream Content in Wilson's Disease with and without REM Sleep Behaviour Disorder: A Neurooneirologic Study. Tribl GG; Trindade MC; Schredl M; Pires J; Reinhard I; Bittencourt T; Lorenzi-Filho G; Alves RC; de Andrade DC; Fonoff ET; Bor-Seng-Shu E; Machado AA; Teixeira MJ; Barbosa ER Behav Neurol; 2016; 2016():2983205. PubMed ID: 27051076 [TBL] [Abstract][Full Text] [Related]
29. Chronic exposure to dopamine agonists affects the integrity of striatal D Politis M; Wilson H; Wu K; Brooks DJ; Piccini P Neuroimage Clin; 2017; 16():455-460. PubMed ID: 28879087 [TBL] [Abstract][Full Text] [Related]
30. Daydreams and nap dreams: Content comparisons. Carr M; Nielsen T Conscious Cogn; 2015 Nov; 36():196-205. PubMed ID: 26164253 [TBL] [Abstract][Full Text] [Related]
32. The effect of dopaminergic medication on conflict adaptation in Parkinson's disease. Ruitenberg MFL; Abrahamse EL; Santens P; Notebaert W J Neuropsychol; 2019 Mar; 13(1):121-135. PubMed ID: 28714199 [TBL] [Abstract][Full Text] [Related]
33. Dream features in the early stages of Parkinson's disease. Bugalho P; Paiva T J Neural Transm (Vienna); 2011 Nov; 118(11):1613-9. PubMed ID: 21717220 [TBL] [Abstract][Full Text] [Related]
34. Dopamine agonists and sleep in Parkinson's disease. Cantor CR; Stern MB Neurology; 2002 Feb; 58(4 Suppl 1):S71-8. PubMed ID: 11909988 [TBL] [Abstract][Full Text] [Related]
36. Use of varenicline in smokeless tobacco cessation influences sleep quality and dream recall frequency but not dream affect. Polini F; Principe R; Scarpelli S; Clementi F; De Gennaro L Sleep Med; 2017 Feb; 30():1-6. PubMed ID: 28215231 [TBL] [Abstract][Full Text] [Related]
37. Recalling and forgetting dreams: theta and alpha oscillations during sleep predict subsequent dream recall. Marzano C; Ferrara M; Mauro F; Moroni F; Gorgoni M; Tempesta D; Cipolli C; De Gennaro L J Neurosci; 2011 May; 31(18):6674-83. PubMed ID: 21543596 [TBL] [Abstract][Full Text] [Related]
38. Weak electromagnetic fields restore dream recall in patients with multiple sclerosis. Sandyk R Int J Neurosci; 1995 May; 82(1-2):113-25. PubMed ID: 7591509 [TBL] [Abstract][Full Text] [Related]